• Maria DRAGAN “Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • Catalina Daniela STAN “Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • Andreea Teodora IACOB “Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • Oana DRAGOSTIN Dunărea de Jos” University Galaţi
  • Lenuta PROFIRE “Grigore T. Popa” University of Medicine and Pharmacy Iasi


Ferulic acid is a phenolic compound that was first isolated in 1866 from the Ferula foetida resin (Apiaceae family) and was later obtained by synthesis. In nature, ferulic acid is found both in free and conjugated form. Due to its antioxidant effects ferulic acid can be used in the prevention and the therapy of diseases induced by oxidative stress, including Alzheimer's disease, diabetes mellitus, cancer, hypertension and atherosclerosis. The strong link between inflammation and oxidative stress suggests that ferulic acid can also be effective in the treatment of inflammatory conditions. Moreover, the specific ferulic acid structure also gives it a strong UV absorption capacity, making it a promising photoprotective agent.

Author Biographies

Maria DRAGAN, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

Faculty of Pharmacy
Department of Pharmaceutical Sciences (II)

Catalina Daniela STAN, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

Faculty of Pharmacy
Department of Pharmaceutical Sciences (II)

Andreea Teodora IACOB, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

Faculty of Pharmacy
Department of Pharmaceutical Sciences (I)

Oana DRAGOSTIN, Dunărea de Jos” University Galaţi

Faculty of Medicine and Pharmacy
Department of Pharmaceutical Science

Lenuta PROFIRE, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

Faculty of Pharmacy
Department of Pharmaceutical Sciences (I)


1. Graf E. Antioxidant potential of ferulic acid. Free Radic Biol Med 1992; 13: 435-448.
2. Mattila P, Pihlava JM, Hellstrom J. Contents of phenolic acids, alkyl-and alkenyl resorcinol, and avenanthramides in commercial grain products. J Agric Food Chem 2005; 53: 8290-8295.
3. Sakakibara H, Honda Y, Nakagawa S, Ashida H, Kanazawa K. Simultaneous determination of all polyphenols in vegetables, fruit and teas. Contents of phenolic acids, alkyl-and alkenyl resorcinols, and avenanthramides in commercial grain products. J Agric Food Chem 2003; 51: 571-581.
4. Virgili F, Pagana G, Bourne L, Rimbach G, Natella F, Rice-Evans C et al. Ferulic acid excretion as a marker of consumption of a French maritime pine (Pinus maritima) bark extract. Free Radic Biol Med 2000; 28: 1249-1256.
5. Wolszleger (Drăgan) M, Stan CD, Pânzariu A, Jităreanu A, Profire L. New thiazolidin-4-ones of ferulic acid with antioxidant potential. Farmacia 2015; 63(1): 150-154.
6. Wolszleger (Drăgan) M, Stan CD, Aprotosoaiei M, Vasincu I, Pânzariu A, Profire L.New hidrazones of ferulic acid: synthesis, characterization and biological activity. Rev Med Chir Soc Med Nat Iaşi 2014; 118(4): 1150-1156.
7. Stan CD, Drăgan M, Pânzariu A, Profire L. Assessment of in vitro antioxidant activity of some new ferulic acid derivatives. Rev Med Chir Soc Med Nat Iaşi 2016; 120(3): 727-731.
8. Kumar N, Pruthi V. Potential applications of ferulic acid from natural sources. Biotechnology Reports 2014; 4: 86-93.
9. Drăgan M, Stan CD, Pânzariu A, Profire L. Assessment of in vitro antioxidant and anti-inflammatory activities of new azetidin-2-ones’ derivatives of ferulic acid. Farmacia 2016; 64(5): 717-721.
10. Drăgan M, Stan CD, Pânzariu A, Profire L. Evaluation of anti-inflammatory potential of some new ferulic acid derivatives. Farmacia 2016; 64(2): 194-197.
11. Wang BH, Ou-Yang JP. Pharmacological actions of sodium ferulate in cardiovascular system. Cardi-ovascular Drug Rewiews 2005; 23: 161-172.
12. Fetoni AR, Mancuso C, Eramo SL, Ralli M, Piacentini R, Barone E et al. In vivo protective effect of ferulic acid against noise-induced hearing loss in the guinea-pig. Neuroscience 2010; 169(4): 1575-1588.
13. Trombino S, Cassano R, Ferrarelli T, Barone E, Picci N, Mancuso C. Trans-ferulic acid-based solid lipid nanoparticles and their antioxidant effect in rat brain microsomes. Colloids Surf B: Biointerf 2013; 109: 273-279.
14. Kanski J, Aksenova M, Stoyanova A, Butterfield DA. Ferulic acid antioxidant protection against hydroxyl and peroxyl radical oxidation in synaptosomal and neuronal cell culture systems in vitro: structure-activity studies. J Nutr Biochem 2002; 13: 273-281.
15. Sirinivasan M, Sudheer AR, Pillai KR, Kumar PR, Sudhakaran PR, Menon VP. Influence of ferulic acid on gamma-radiation induced DNA damage, lipid peroxidation and antioxidant status in primary culture of isolated rat hepatocytes. Toxicology 2006; 228: 249-258.
16. Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E. Alzheimer’s disease. Lancet 2011; 377: 1019-1031.
17. Querfurth HW, LaFerla FM. Alzheimer disease. N Engl J Med 2010; 362: 329-344.
18. Butterfield DA, Reed T, Newman SF, Sultana R. Roles of amyloid beta-associated oxidative stress and brain protein modification in the pathogenesis of Alzheimer’s disease and mild cognitive impairment. Free Radic Biol Med 2007; 43: 658-677.
19. Ferrer I. Altered mitochondria, energy metabolism, voltage-dependent anion channel, and lipid rats converge to exhaust neurons in Alzheimer’s disease. J Bioenerg Biomembr 2009; 41: 425-431.
20. Bayer TA, Schafer S, Breyhan H, Wirths O, Treiber C, Multhaup G. A vicious circle: role of oxidative stress, intraneuronal Abeta and Cu in Alzheimer’s disease. Clin Neuropathol 2006; 25: 163-171.
21. Calabrese V, Mancuso C, Calvani M, Rizzarelli E, Butterfield DA, Stella AM. Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity. Nat Rev Neurosci 2007; 8: 766-775.
22. Grothe M, Zaborszky L, Atienza M, Gil-Neciga E, Rodriguez-Romero R, Teipel SJ et al. Reduction of basal forebrain cholinergic system parallels cognitive impairment in patients at high risk of developing Alzheimer’s disease. Cereb Cortex 2010; 20: 1685-1695.
23. Mori T, Koyama N, Guillot-Sestier MV, Tan J, Town T. Ferulic acid is a nutraceutical β-secretase modulator that improves behavioral impairment and Alzheimer-like pathology in transgenic mice. PloS One 2013; 8(2): e55774.
24. Jin Y, Yan EZ, Li XM, Fan Y, Zhao YJ, Liu Z et al. Neuroprotective effect of sodium ferulate and signal transduction mechanism in the aged rat hippocampus. Acta Pharmacol Sin 2008; 29: 1399-1408.
25. Mamiya T, Kise M, Morikawa K. Ferulic acid attenuated cognitive deficits and increase in carbonyl proteins induced by buthionine-sulfoximine in mice. Neurosci Lett 2008; 430: 115-118.
26. Menter DG, Schilsky RL, DuBois RN. Cyclooxygenase-2 and cancer treatment: understanding the risk should be worth the reward. Clin Cancer Res 2010; 16: 1384-1390.
27. Fong Y, Tang CC, Hu HT, Fang HY et al. Inhibitory effect of trans-ferulic acid on proliferation and migration of human lung cancer cells accompanied with increased endogenous reactive oxygen species and β-catenin instability. Chin Med 2016; 11: 45-50.
28. Sakthi PS, Vijayalakshmi G. Therapeutical properties of ferulic acid and bioavailability enhancement through feruloyl esterase. Journal of Functional Foods 2015; 17: 656-666.
29. Sudheer AR, Muthukumaran S, Kalpana C, Srinivasan M, Menon VP. Protective effect of ferulic acid on nicotine-induced DNA damage and cellular changes in cultured rat peripheral blood lymphocytes: a comparison with N-acetylcysteine. Toxicol In Vitro 2007; 21(4): 576-585.
30. Jayaprakasam B, Vanisree M, Zhang Y. Impact of alkyl esters of caffeic and ferulic acids on tumor cell proliferation, cyclooxigenase enzyme and lipid peroxidation. Contents of phenolic acids, alkyl-and alkenylresorcinols, and avenanthramides in commercial grain products. J Agric Food Chem 2009; 54: 5375-5381.
31. Baskaran N, Monoharan S, Balakrishnan S, Pugalendhi P. Chemopreventive potential of ferulic acid in 7,12-dimethylbenzanthracene-induced mammary carcinogenesis in Sprague-Dawley rats. Eur J Pharmacol 2010; 637: 22-29.
32. Hemaiswarya S, Doble M. Combination of phenylpropanoids with 5-fluorouracil as anti-cancer agents against human cervical cancer (HeLa) cell line. Phytomedicine 2013; 20: 151-158.
33. Bandugula VR, Prasad NR. 2-Deoxy-d-glucose and ferulic acid modulates radiation response signaling in non-small cell lung cancer cells. Tumor Biol 2013; 34: 251-259.
34. Pagidipati NJ, Gaziano TA. Estimating deaths from cardiovascular disease: a review of global meth-odologies of mortality measurement. Circulation 2013; 127: 749-756.
35. Alam MA, Sernia C, Brown L. Ferulic acid improves cardiovascular and kidney structure and function in hypertensive rats. J Cardiovasc Pharmacol 2013; 61: 240-249.
36. Suzuki A, Yamamoto M, Jokura H, Fujii A, Tokimitsu I, Hase T, Saito I. Ferulic acid restores endo-thelium-dependent vasodilation in aortas of spontaneously hypertensive rats. Am J Hypertens 2007; 20: 508-513.
37. Wang B, Ou-Yang J, Liu Y, Yang J, Wei I, Li K, Yang H. Sodium ferulate inhibits atherosclerogenesis in hyperlipidemia rabbits. J Cardiovasc Pharmacol 2004; 43: 549-554.
38. Zhou T, Zeng QT, Zhang GQ, Liu JH, Li P, MaoY. Effect of sodium ferulate on experimental adrena-line-induced arrhythmias. Chin J New Drugs 2003; 12: 344-346.
39. Wang BH, Ou-Yang JP. Pharmacological action of sodium ferulate in cardiovascular system. Cardio-vasc. Drug Rev 2005; 23(2): 161-172.
40. Zhang J, Chen J, Yang J, Xu C, Ding J, Yang J, Guo Q, Hu Q, Jiang H. Sodium Ferulate Inhibits Neointimal Hyperplasia in Rat Balloon Injury Model. PLoS One 2014; 9(1): e87561.
41. Naudi A, Jove M, Ayala V, Cassanye A, Serrano J, Gonzalo H et al. Cellular dysfunction in diabetes as maladaptive response to mitochondrial oxidative stress. Exp Diabets Res 2012; 2012: 696215.
42. Roy S, Metya SK, Sannigrahi S, Raharnan N, Ahmed F. Treatment with ferulic acid to rats with streptozotocin-induced diabets: effects on oxidative stress, pro-inflammatory cytokines and apoptosis in the pancreatic β cell. Endocrine 2013; 44: 369-379.
43. Jung EH, Kim SR, Hawang IK, Ha TY. Hypoglicemic effects of a phenolic acid fraction of rice bran and ferulic acid in C57BL/KsJ-db/db mice. J Agric Food Chem 2007; 55: 9800-9804.
44. Choi R, Kim BH, Naowaboot J, Lee MY, Hyun MR, Cho EJ, Lee ES, Lee EY, Yang YC, Chung CH. Effects of ferulic acid on diabetic nephropathy in a rat model of type 2 diabetes. Exp Mol Med 2011; 43: 676-683.
45. Lin FH, Lin JY, Gupta RD, Tournas JA, Burch JA, Selim MA et al. Ferulic acid stabilized a solution of vitamins C and E and doubles its photoprotection of skin. J Invest Dermatol 2005; 125: 826-832.
46. Lin JY, Tournas JA, Burch JA et al. Topical isoflavones provide effective photoprotection to skin. Photodermatol Photoimmunol Photomed 2008; 24: 61-66.